AEON Biopharma, Inc. (AEON)
- Previous Close
4.6600 - Open
4.8600 - Bid --
- Ask 12.5000 x 1000
- Day's Range
4.5100 - 5.1400 - 52 Week Range
3.3700 - 17.1700 - Volume
72,426 - Avg. Volume
62,712 - Market Cap (intraday)
179.928M - Beta (5Y Monthly) 0.41
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
www.aeonbiopharma.comRecent News: AEON
Performance Overview: AEON
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AEON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AEON
Valuation Measures
Market Cap
179.93M
Enterprise Value
175.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-3.62
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-374.77%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-36.63M
Diluted EPS (ttm)
-0.9700
Balance Sheet and Cash Flow
Total Cash (mrq)
5.16M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-25.48M